Bruce Robinson
Overview
Explore the profile of Bruce Robinson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
156
Citations
6787
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pandey K, Faridi P, Ayala R, Lee Y, Rouse E, Krishna S, et al.
Mol Cell Proteomics
. 2025 Feb;
24(3):100925.
PMID: 39921204
Mesothelioma is an incurable, asbestos-exposure-related cancer that typically affects the lining or pleura of the lungs. Symptoms typically develop many decades after initial asbestos exposure, leaving an enduring legacy of...
2.
Papachristos A, Zhou L, Sheen A, Sywak M, Robinson B, Clifton-Bligh R, et al.
Thyroid
. 2025 Jan;
PMID: 39868721
Tumor-infiltrating lymphocytes (TILs) are a protective prognostic factor in several solid tumors and predict response to immune checkpoint inhibitor therapy. The prognostic impact of TILs in medullary thyroid cancer (MTC)...
3.
Wijewardene A, Gild M, Tacon L, Tsang V, Gill A, Glover A, et al.
Endocr Connect
. 2024 Sep;
13(11).
PMID: 39283868
Background: Noise, an unwanted variability in judgment, is ubiquitous in medicine, including in the prescription of radioactive iodine (RAI). Building upon our recently developed predictive risk model, we created an...
4.
Lawless A, Kumar S, Bindra J, Sywak M, Chou A, Turchini J, et al.
Asia Pac J Clin Oncol
. 2024 Aug;
20(6):681-689.
PMID: 39145924
Anaplastic thyroid cancer (ATC), a rare and highly aggressive malignancy, is characterized by an exceptionally poor prognosis, where the majority of patients present with extensive local invasion and/or distant metastases....
5.
Wirth L, Brose M, Subbiah V, Worden F, Solomon B, Robinson B, et al.
J Clin Oncol
. 2024 Aug;
42(27):3187-3195.
PMID: 39094065
JCO LIBRETTO-001 is a registrational phase I/II, single-arm, open-label study of selpercatinib in patients with (REarranged during Transfection)-activated cancers (ClinicalTrials.gov identifier: NCT03157128). We present long-term safety and efficacy from LIBRETTO-001...
6.
Hanafusa N, Henn L, Bieber B, Hasegawa T, Usui T, Robinson B, et al.
Ther Apher Dial
. 2024 Jul;
29(1):23-33.
PMID: 38962901
Introduction: Ferritin level and erythropoiesis-stimulating agent (ESA) responsiveness are each associated with hemodialysis patient survival. We assessed interrelationships between these two vs. survival. Methods: Patients in the Japan Dialysis Outcomes...
7.
Mancini V, Nevill T, Mazzucchelli T, Chhabra J, Robinson B
Br J Educ Psychol
. 2024 Jun;
94(4):1033-1051.
PMID: 38890120
Background: Parent involvement strongly correlates with children's educational attainment. Sociocultural shifts in parenting roles and shared responsibilities have driven an increase in the need for involvement of fathers in activities...
8.
Yamamoto S, Jorgensen H, Zhao J, Karaboyas A, Komaba H, Vervloet M, et al.
Kidney Int Rep
. 2024 May;
9(4):863-876.
PMID: 38765600
Introduction: Secondary hyperparathyroidism (SHPT) increases the risk of fractures and cardiovascular (CV) disease in patients on hemodialysis (HD). The relationship between parathyroid hormone (PTH) and outcomes has been inconsistent, possibly...
9.
Russell M, Gild M, Wirth L, Robinson B, Karcioglu A, Iwata A, et al.
Head Neck
. 2024 Mar;
46(10):2496-2507.
PMID: 38488238
Background: Experience with targeted neoadjuvant treatment for locoregionally advanced thyroid cancer is nascent. Methods: Multicenter retrospective case series examining targeted neoadjuvant treatment for locoregionally advanced thyroid cancer. The primary outcome...
10.
Zeng P, Prokopec S, Lai S, Pinto N, Chan-Seng-Yue M, Clifton-Bligh R, et al.
Cell Rep
. 2024 Feb;
43(3):113826.
PMID: 38412093
Anaplastic thyroid carcinoma is arguably the most lethal human malignancy. It often co-occurs with differentiated thyroid cancers, yet the molecular origins of its aggressivity are unknown. We sequenced tumor DNA...